Goldman Sachs Group Inc Pfizer Inc Transaction History
Goldman Sachs Group Inc
- $605 Billion
- Q3 2024
A detailed history of Goldman Sachs Group Inc transactions in Pfizer Inc stock. As of the latest transaction made, Goldman Sachs Group Inc holds 25,826,618 shares of PFE stock, worth $644 Million. This represents 0.12% of its overall portfolio holdings.
Number of Shares
25,826,618
Previous 34,916,739
26.03%
Holding current value
$644 Million
Previous $977 Million
23.5%
% of portfolio
0.12%
Previous 0.17%
Shares
19 transactions
Others Institutions Holding PFE
# of Institutions
3,256Shares Held
3.62BCall Options Held
77.2MPut Options Held
122M-
Vanguard Group Inc Valley Forge, PA516MShares$12.9 Billion0.27% of portfolio
-
Black Rock Inc. New York, NY424MShares$10.6 Billion0.27% of portfolio
-
State Street Corp Boston, MA290MShares$7.24 Billion0.35% of portfolio
-
Wellington Management Group LLP Boston, MA164MShares$4.08 Billion0.85% of portfolio
-
Charles Schwab Investment Management Inc San Francisco, CA130MShares$3.25 Billion0.73% of portfolio
About PFIZER INC
- Ticker PFE
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 5,612,349,952
- Market Cap $140B
- Description
- Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...